Navigation Links
Cantel Medical Corp. to Present at the CL King 9th Annual Best Ideas Conference
Date:8/31/2011

LITTLE FALLS, N.J., Aug. 31, 2011 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the CL King 9th Annual Best Ideas Conference. The formal presentation is scheduled for 11:15 AM EDT on Tuesday, September 13, 2011 at the Omni Berkshire Place Hotel in New York City, with a Q & A session immediately following the presentation. In addition, Mr. Krakauer and Seth R. Segel, Executive Vice President, will be available for separate one-on-one meetings during the day. The presentation will be available on the Investor Relations section of the Company's website: www.cantelmedical.com.

About Cantel Medical Corp.

Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for the dental industry, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.  For further information, visit the Cantel website at http://www.cantelmedical.com.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Cantel Medical Acquires Byrne Medical, Inc., Substantially Increasing Its Presence in GI Endoscopy
2. Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales
3. Cantel Medical Corp. to Present at the Needham & Company 10th Annual Healthcare Conference
4. Ann E. Berman To Join the Board of Directors of Cantel Medical Corp.
5. Cantel Medical Corp. to Present at The Sidoti & Company LLC Fifteenth Annual Emerging Growth Institutional Investor Forum
6. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2011
7. Dr. Peter J. Pronovost to Join the Board of Directors of Cantel Medical Corp.
8. Cantel Medical Board of Directors Authorizes Increase in Semiannual Dividend
9. Cantel Medical Corp. Launches New Medical Face Mask Addressing Issue of Fit
10. Cantel Medical Corp. to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2010 Results
11. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Third Quarter Ended April 30, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Boehringer Ingelheim will contribute to advancing the ... Thoracic Society International Conference (ATS 2013) in ... 22. Data will highlight research conducted ... chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® (tiotropium ... for asthma, idiopathic pulmonary fibrosis (IPF) and COPD. ...
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ... today that the United States Food and Drug Administration ... for ORMD-0801, its oral insulin capsule. "We ... proceed," stated Nadav Kidron , CEO ... for Oramed and we look forward to continuing to ...
(Date:5/16/2013)... Ill. and MECHELEN, Belgium ... GLPG) and AbbVie (NYSE: ABBV ) announced ... to include Crohn,s disease.  Galapagos will fund and complete ... designed to facilitate rapid progression into Phase 3.  Upon ... AbbVie will pay Galapagos $50 million.  The terms of ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... of Regulatory Submissions Leadership Strengthened with Clinical ... Trials Services and Standards-Based Data Management, WHIPPANY, ... (ISI) announced today it agreed to terms to ... industry moving to,standards-based regulatory submissions, the acquisition further ...
... the First Hsp90 Inhibitor to Enter Registration Trials, ... KOSN ) today announced that it has successfully,reached a ... on the design of its TIME-1 clinical trial, a ... a treatment for patients with,multiple myeloma. Through the FDA,s ...
Cached Medicine Technology:Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 2Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
(Date:5/20/2013)... Nashville, TN (PRWEB) May 20, 2013 Along ... Warren Melamed has remained a fervent proponent of regular ... appropriate brushing and flossing twice a day. While these recommendations ... of tooth decay reveal that most adults and children are ... patients must find a new way to break into the ...
(Date:5/20/2013)... Senior Solutions Management Group (SSMG), a ... Southeast, today announced that four of its Resident Assistants ... communities have received The Caring Heart Award from Alzheimer’s ... Loudon, Nicole Braden from River Oaks Place in Loudon, ... and Meghan McCormick from Wellspring Senior Living in Knoxville ...
(Date:5/20/2013)... 2013 The main objective for the present ... into a single comprehensive report. The objective was to ... this industry. Thus, it is timely to examine the ... an urgent need in the life science industry for technologies ... in a high-throughput, multiplex and low-cost way. Proteomic technologies ...
(Date:5/20/2013)... Idol lash has designed its brand new ... eyelashes in a matter of few weeks. It is completely ... an extra pack offer to help more women achieve broad ... on the Idol lash official website. , Numerous trials were ... density up to 82% in just a few weeks. According ...
(Date:5/20/2013)... The Semi Truck Accident Victims ... free service for an innocent victim of a catastrophic ... state our services are unparalleled. What this means is ... victim of a passenger vehicle involved in a semi ... Virginia, Ohio, New Jersey, Indiana, Maryland, Georgia, Nebraska, Kansas, ...
Breaking Medicine News(10 mins):Health News:New AirFloss Product Offers Oral Hygiene Innovation, Dental Professional Warren Melamed Comments 2Health News:Senior Solutions Management Caregivers Receive Caring Heart Award From Alzheimer’s Tennessee 2Health News:Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com 2Health News:Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com 3Health News:Idol Lash Eyelash Growth Enhancer Now Offered Extra Pack for Limited Time Only at HealthCareSupplementz.com 2Health News:Semi Truck Accident Victims Center Urges Family Members Of Victims Injured In A Horrific Semi Truck Accident In Any US State To Call Them First For An Unsurpassed Response 2
... swallowing the mobile phone by a 24 year women was an ... // The Blue Spring Police are investigated the incident in which ... phone during an argument with her boy friend in which she ... friend. Police got a phone call from her boyfriend that her ...
... Hewitt, the Health Secretary of the UK has imposed a ... //This move has raised doubts as to whether the private ... the NHS will be put into operation. ,The ... ?1 billion plan has been questioned by Ms Hewitt. The ...
... erythematosus (lupus) is a disease in which the body's ... the skin, joints and internal organs.// A study has ... take oral contraceptives safely without any complications like increased ... that characterize the disease. ,The study was ...
... scanner has been developed for premature and newborn babies that ... how the baby brain is working. ,Currently, there are ... Magnetic resonance imaging (MRI) can provide data on brain ... of risk. ,The alternative, ultrasound, can be performed ...
... health benefits of milk thistle, an herbal remedy employed in ... recent study highlighting the lack of evidence for its safety ... for thistle milk, with over 1 million people suffering from ... worldwide. ,The research team analyzed the results of ...
... been passed by the Food and Drug Administration (FDA) saying that ... to be mentioned in the label of the product. ... milk, eggs, fish, crustaceans, wheat, tree nuts, soybeans and peanuts. ... allergies are one of the major causes of death in US. ...
Cached Medicine News:Health News:Milk Thistle Not An Effective Cure For Liver Disease 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: